Study details
Enrolling now
Liver Cancer Disparities in American Indian and Alaska Native Persons
University of Washington
NCT IDNCT05304234ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
200
Study length
about 4.4 years
Ages
18–75
Locations
1 site in OK
What this study is about
Researchers are testing whether an abbreviated MRI plus AFP screening every 6 months is as effective as the current standard of care (ultrasound plus AFP screening) for detecting liver cancer in American Indian and Alaska Native people with cirrhosis or hepatitis B. The trial will involve approximately 200 participants who are adults, and it will last about 1614 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Ultrasound or abbreviated MRI
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
imaging
Body systems
Infectious